Spots Global Cancer Trial Database for appendiceal cancer
Every month we try and update this database with for appendiceal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| Genetics of Appendix Cancer Study | NCT05734430 | Appendix Cancer Appendiceal Can... Appendiceal Neo... Appendiceal Muc... Appendiceal Ade... Appendiceal Car... Appendiceal Neo... Appendix Adenoc... Appendix Mucino... Appendix Tumor Appendix Cancer... Appendix NET Low-Grade Appen... High Grade Appe... High Grade Appe... | Genetic profili... Retrospective t... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies | NCT02963831 | Colorectal Canc... Ovarian Cancer Appendiceal Can... | ONCOS-102 Durvalumab Cyclophosphamid... | 18 Years - | Ludwig Institute for Cancer Research | |
| Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei | NCT01946854 | Gastrointestina... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma | NCT05452382 | Appendiceal Can... | Partial colecct... Hemicolectomy | - | Mansoura University | |
| Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | NCT03604653 | Stomach Cancer Colorectal Canc... Appendiceal Can... Ovarian Cancer Uterine Cancer Cervical Cancer Fallopian Tube ... Primary Periton... | HIPEC Mitomycin c CDDP 50 CDDP 75 Doxorubicin | 18 Years - | Holy Name Medical Center, Inc. | |
| Genetics of Appendix Cancer Study | NCT05734430 | Appendix Cancer Appendiceal Can... Appendiceal Neo... Appendiceal Muc... Appendiceal Ade... Appendiceal Car... Appendiceal Neo... Appendix Adenoc... Appendix Mucino... Appendix Tumor Appendix Cancer... Appendix NET Low-Grade Appen... High Grade Appe... High Grade Appe... | Genetic profili... Retrospective t... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer | NCT04158349 | Colorectal Canc... Appendiceal Can... Peritoneal Carc... | Oxaliplatin mFOLFIRI | 18 Years - | University of Utah | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation | NCT05194995 | Advanced Colore... Small Intestina... Appendiceal Can... | JAB-21822 Cetuximab | 18 Years - | Jacobio Pharmaceuticals Co., Ltd. | |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation | NCT05194995 | Advanced Colore... Small Intestina... Appendiceal Can... | JAB-21822 Cetuximab | 18 Years - | Jacobio Pharmaceuticals Co., Ltd. | |
| Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | NCT06101277 | Esophageal Canc... Small Bowel Can... Gastroesophagea... Gastric Cancer Colorectal Canc... Appendiceal Can... Biliary Cancer Gall Bladder Ca... Intrahepatic Ch... Extrahepatic Ch... Oligoprogressiv... | Ablative local ... | 18 Years - | University of California, Davis | |
| Molecular Characterisation of Appendiceal Cancer | NCT05364788 | Appendiceal Can... | Retrospective t... | 18 Years - | The Christie NHS Foundation Trust | |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer | NCT04158349 | Colorectal Canc... Appendiceal Can... Peritoneal Carc... | Oxaliplatin mFOLFIRI | 18 Years - | University of Utah |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
